Journal
EXPERT OPINION ON DRUG DELIVERY
Volume 5, Issue 9, Pages 927-929Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17425247.5.9.927
Keywords
liposome; nanoparticle; nanotechnology
Categories
Funding
- NCI NIH HHS [CA119349] Funding Source: Medline
- NIBIB NIH HHS [EB003647] Funding Source: Medline
Ask authors/readers for more resources
The pipelines of pharmaceutical companies are in many cases believed to be drying up and many blockbuster drugs are expected to be coming off patent in the near term. The application of nanotechnology to drug delivery is widely expected to create novel therapeutics capable of changing the landscape for pharmaceutical and biotechnology industries. This editorial highlights the nanotechnology platforms that are under development or in clinical use today, and points to exciting areas of opportunity where nanotechnology may enable the development of more effective and safer targeted therapeutics for a myriad of clinical applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available